Erika Tyburski

Erika Tyburski is the CEO and co-founder of Sanguina, a biotech company that creates accessible tools for diagnosing, monitoring and managing health and wellness via a digital health platform and test kits. Their first platform for anemia management, AnemoCheck, consists of point-of-care and home testing and the world’s first smartphone application for anemia management with a fingernail selfie. Erika is a biomedical engineer and entrepreneur out of Georgia Tech with hands-on experience in bench-to-bedside development, clinical testing, regulatory strategies, operations, fundraising, and team expansion. She has managed over $3.5M in non-dilutional grant funding and over $3M in private investment for Sanguina and is also part of the Forbes 30 Under 30 Healthcare class of 2020.